Veriheal

MARCH 23, 2023

Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products. The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan.

Legalization 58

Legalization Marijuana Clinical Trials Seed-To-Sale 58

WeedAdvisor

MAY 30, 2019

That is until the FDA made a decision that made pharmaceutical history. Epidiolex, a drug used to treat severe childhood epilepsy, became the first FDA-approved drug derived entirely from CBD isolate. But being an FDA-approved pharmaceutical product, its status is no different than a bottle of aspirin. Limitations.

Oil 49

Oil CBD Hemp Policy 49

Canna Law Blog

OCTOBER 31, 2019

Epidiolex is a drug that was created by Cambridge, UK-based GW Pharmaceuticals and was approved by the FDA as a drug in 2018 to help relieve epilepsy-induced seizures. GW Pharmaceuticals has now done two decades’ worth of research on CBD and other cannabinoids and is responsible for putting CBD on the FDA’s radar many years ago.

Pharmaceutical 54

Pharmaceutical Research and Development Cannabinoids Food 54

Cannabis Law Report

FEBRUARY 15, 2019

The Singapore Online Citizen reports… Law & Home Affairs Minister K Shanmugam says that pharmaceutical companies are hiding their intentions behind a smokescreen when it comes to cannabis. These can be administered through pharmaceutical products such as oral solutions and sprays.

Medicine 45

Medicine Pharmaceutical Law Cannabinoids 45

Veriheal

JANUARY 12, 2023

The law also permits the agricultural production of cannabis and hemp for industrial purposes, with a heavy emphasis on pharmaceutical crops. . Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023.

Medicine 81

Medicine Chronic Pain Consumption Cannabis 81

The Cannigma

FEBRUARY 21, 2021

Some of them are the same people who have been steering the cannabis industry since its infancy, others are massive beer and pharmaceutical companies, and some come from more unexpected places. billion by Jazz Pharmaceuticals, reportedly the largest-ever deal in the medical cannabis sector. Darrin Harris Frisby/Drug Policy Alliance).

Research and Development 118

Research and Development Pharmaceutical Recreational Cannabis 118

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 14, 2019

Agriculture Commissioner Nikki Fried announced Monday a new Medical Marijuana Advisory Committee, which she says will collaborate with the Florida Department of Agriculture and Consumer Services to help improve the state’s medical marijuana policies. Geller’s work focuses on cannabis policy development at the state and federal levels.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

Cannabis Law Report

NOVEMBER 22, 2019

In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition.

Sativa 59

Sativa Medicine Legalization Epilepsy 59

WeedAdvisor

MAY 28, 2019

Released by GW Pharmaceuticals, this drug came after years of investigation into the therapeutic properties of CBD on epilepsy. Following several studies, researchers found that CBD provided partial or total seizure relief to children with severe epilepsy, specifically Lennox Gastaut Syndrome and Dravet Syndrome.

Hemp 45

Hemp Legalization Epilepsy CBD 45

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. Norway has not legalized recreational cannabis but typically possession of less than 15 grams is punished with a simple fine. How do Norwegians generally view marijuana?

Legalization 59

Legalization Decriminalization Patients Medicine 59

The Joint Blog

FEBRUARY 24, 2022

It is slowly gaining recognition in several countries because of the legalization policies. Further, the adoption of regulatory relaxations and favorable policies is expected to boost the product’s adoption. Furthermore, marijuana’s demand is increasing rapidly from the medical sector because of relaxation policies.

Business 26

Business Research and Development Chronic Pain Policy 26

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e.,

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Cannabis Law Report

JULY 13, 2019

After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. We heard throughout our inquiry that some pharmaceutical companies were not willing to provide their product for trial,” the report says.

Research and Development 40

Research and Development Clinical Trials Epilepsy Patients 40

Canna Law Blog

MARCH 7, 2019

Yet, as of the date of this post, the FDA has only approved CBD as a pharmaceutical drug in the treatment of epilepsy ( Epidiolex ). Therefore, any health claim made about CBD-infused products, including CBD Smokables, will be treated by the FDA as a drug. Drugs are tightly regulated by the FDA and are subject to pre-market approval.

CBD 77

CBD Legalization Food Epilepsy 77

Cannabis Law Report

JUNE 26, 2019

In May 2019, Florida Commissioner of Agriculture Nikki Fried announced that a newly-created and appointed Medical Marijuana Advisory Committee of 18 doctors, lawyers, patients, industry leaders, and advocates will be implemented in order to “advance and modernize policies” to move Florida into the future of medical marijuana.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

OCTOBER 20, 2019

They include, but are not limited to, the synthetic marijuana pharmaceutical companies; the Canadian marijuana industry; the alcohol industry; the pharmaceutical industry in general; the drug testing industry, and, the government. xi] “Pharmaceutical Research and Manufacturers of America (PhRMA) spent $19.7

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

JANUARY 28, 2020

However, and contrary to the US and Canada, no EU-wide policy for medical cannabis has been enacted yet. Policy confusion within the EU. In this resolution, the European Commission and the member states are urged to work on the legal framework of, and the research into, the use of cannabis for medicinal purposes.

Medicine 59

Medicine Cultivation Research and Development Policy 59

Cannabis Law Report

MAY 7, 2019

These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US. is an emerging pharmaceutical and IP development company, who, through its 100% owned subsidiary Cannevert Therapeutics Ltd. (“CTL“), Source: [link]. Veritas Pharma to Commence Legal Proceedings Against Liht Cannabis.

Compliance 63

Compliance Compliance Research and Development Strains 63

Cannabis Law Report

JUNE 1, 2021

Steve Barbera is an accomplished cross-functional leader in the healthcare industry, with over 20 years of experience in the development and implementation of complex market access strategies including health policy, pricing and reimbursement, contracts and coding.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

The Joint Blog

SEPTEMBER 9, 2020

Even the Food and Drug Administration body in the US has approved a medicine based on CBD to treat childhood epilepsy. CBD Oil Is Becoming Legal in Many Countries The general public, including the governments around the world, have recognized the benefits of CBD and its potential in the medical and pharmaceutical industry.

Oil 49

Oil CBD Vaping Hemp 49

Cannabis Law Report

APRIL 10, 2019

Hancock’s response called out the very companies that are pushing to provide or import cannabis oils, suggesting they ought to support necessary research: “…it is vital to bring forward these clinical trials, and [the] pharmaceutical companies that provide the oils have not pushed forward the trials in the way that would normally happen.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

The Cannigma

AUGUST 29, 2021

The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”. Get your medical card now with The Cannigma Medical. Marijuana is safe – but there can be side effects.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

Weedistry

JANUARY 30, 2019

These products are also formulated correctly and to what I would call pharmaceutical standards, which is what you want people with compromised immune systems taking into their bodies,” he said. Lobbying and marijuana policy. Used responsibly, marijuana can be a powerful and important tool in a healthy lifestyle.”

Recreational 40

Recreational Marijuana Legislation Patients 40

Cannabis Law Report

JULY 15, 2019

That is yet to be done, and there is no real access without a well-informed medical and pharmaceutical community. Although this list can (and should) be periodically reviewed, Portugal lost an opportunity to expand the access to more patients and give more flexibility to the medical community on the prescription on medical cannabis.

Medicine 40

Medicine Clinical Trials Patients Access 40

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Accessed October 17, 2022. 2021.108514.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

MARCH 3, 2020

Courtney Parker, Pensacola Store Manager amplifies this goal: “At MÜV our main priority is to combine pharmaceutical industry precision with an engaging and compassionate patient experience. The fact that Zappos pays its staff well, provides overnight delivery and has a 365 free returns policy does add to the price of its goods.”

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

Canna Law Blog

OCTOBER 5, 2022

However, if this recommendation is actually taken up by the government, legitimate medical marijuana products may be imported into Japan under its existing laws for pharmaceuticals and medical devices. We could see medical marijuana in Japan in the near future, which would be huge for Asian cannabis policy and the world.

Marijuana 93

Marijuana Seed-To-Sale Clinical Trials Epilepsy 93

Cannabis Law Report

SEPTEMBER 12, 2022

Extracts derived from hemp plants are infused into a variety of products, both ingestible and topical, to produce therapeutic effects, sometimes without the side effects of synthetic pharmaceutical drugs. The FDA also asserted that CBD was considered a drug because FDA had approved Epidiolex, a marijuana derived CBD drug for epilepsy.

Hemp 52

Hemp CBD Food Extraction 52

CannaTech

SEPTEMBER 23, 2019

The pleas of parents fighting to treat their sick children are impossible to ignore, as evidenced by the impact of Billy Caldwell and Alfie Dingley’s parents in shifting the regulatory framework for UK cannabis policy. UK cannabis policy is not serving the interests of patients.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

FEBRUARY 1, 2020

This is because medical marijuana products are not covered under Australia’s Pharmaceutical Benefits Scheme; all medications must be paid for out-of-pocket. Cannabis law and retributional policy vary significantly across Australia, as each district has its own policies , as does the federal Commonwealth. SOUTH KOREA.

Legalization 59

Legalization Research and Development Recreational Access 59

Cannabis Law Report

SEPTEMBER 28, 2019

24 people in Ireland are now being prescribed medicinal cannabis, but it only includes those suffering from multiple sclerosis, epilepsy and post chemotherapy sickness. The text sanctions the total failure of repression policies, citing the now famous 2015 report of the Italian National Anti-Mafia Directorate. San Marino.

Epilepsy 40

Epilepsy Chronic Pain Medicine Pharmaceutical 40

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Conclusions. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

CannaTech

MARCH 29, 2019

While the amendments to the scheduling of marijuana for medical use were intended to increase access, in reality, only patients suffering from epilepsy, MS, side effects of chemotherapy and chronic pain are eligible. Furthermore, currently only the cannabis-derived pharmaceutical products marinol, epidiolex and sativex are approved for use.

Chronic Pain 50

Chronic Pain Access Patients Food 50

The Cannigma

SEPTEMBER 12, 2021

Rather, it was based on a policy that was created in the 1950s, before THC or CBD were isolated and before the endocannabinoid system was discovered. There are clinical studies that show pure cannabis is more efficient than cannabis-based pharmaceuticals, and that it may produce less adverse effects. Is THC safe? Full spectrum.

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it. SM: I think it’s stability.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

JULY 15, 2022

The schedule eight pharmaceutical medicine has gained federal approval to treat conditions including cancer-related pain, nausea and vomiting, multiple sclerosis and epilepsy, and for use in palliative care. We are at the crossroads of good agriculture meets good health care which meets great policy.

Medicine 52

Medicine Patients Media Supply Chain 52